IRSA Inversiones y Representaciones S.A. reports that certain warrant holders exercised their rights between May 11 and 12, 2026. This exercise will result in the issuance and registration of 35,318,802 ordinary shares, each with a face value of ARS 10, and brought in USD 459,146 to the company.
Following these exercises, IRSA’s ordinary shares outstanding increased from 810,797,120 to 846,115,922. A remaining 149,100 warrants were not exercised and expired on May 12, 2026, closing out this warrant program.
IRSA INVESTMENTS & REPRESENTATIONS INC notified the New York Stock Exchange to remove and withdraw the listing and registration of its warrants to purchase common shares from the Exchange under Section 12(b). The Exchange certified compliance with the procedural rules in 17 CFR 240.12d2-2.
IRSA Inversiones y Representaciones reported a sharp earnings improvement for the first nine months of fiscal 2026, with net income of ARS 239,741 million versus ARS 46,497 million a year earlier and total comprehensive income of ARS 238,297 million.
Shareholders’ equity reached ARS 2,038,249 million as of March 31, 2026, while market capitalization was about USD 1,314 million based on 81,079,712 GDS at USD 16.21 each. Cresud owned 53.44% of share capital, with 26,392,876 warrants still outstanding.
Operationally, Adjusted EBITDA from rental segments was ARS 232,327 million, up 4.6% year over year. The company maintained 100% occupancy in its premium office portfolio, opened a new 15,350 sqm GLA office building at Polo Dot and advanced several development projects in Argentina.
IRSA Inversiones y Representaciones S.A. announces the final opportunity for holders to exercise their share warrants on May 11 and 12, 2026, which is also the expiration date. Intermediaries such as Caja de Valores may apply earlier internal cut-off times for receiving instructions.
Each warrant entitles the holder to receive 1.6367 common shares at an exercise price of USD 0.2641 per share. Holders may also use a “Net Exercise with Par Value Contribution” cashless alternative, receiving shares based on the difference between the cash exercise price and the market value before the exercise period, while paying only the par value and any applicable ADS issuance fee.
IRSA Inversiones y Representaciones Sociedad Anónima reports that it will pay the second interest installment on its Fixed Rate Series XXIV Notes on March 31, 2026. These notes have a principal amount of USD 480,454,198, due in 2035, and bear an annual nominal interest rate of 8.00%.
For this period, IRSA will pay interest of USD 19,218,167.92 in cash, with no principal amortization, so the capital outstanding remains USD 480,454,198. Interest will be paid in U.S. dollars through The Bank of New York Mellon to holders of record as of March 30, 2026.
IRSA Investments & Representations Inc. director and ten percent owner Eduardo S. Elsztain reported open-market sales of common shares. He sold 20,000 shares on 2026-03-19 at 2,115 per share and 10,428 shares on 2026-03-18 at 2,156.03 per share, with prices reported in Argentine pesos. After these transactions, he directly held 4,457,258 common shares, indicating that the sales represent a small portion of his overall position.
IRSA Investments & Representations Inc CFO Matias Ivan Gaivironsky filed an amended Form 3 detailing his equity and derivative holdings. He directly holds 229,787 common shares and 9,817 ADS. He also holds restricted share units tied to 215,111 underlying common shares granted on March 17, 2026, which are scheduled to vest in two tranches of 107,555 common shares in January 2027 and 107,556 common shares in January 2028. In addition, he holds warrants linked to 130,018 underlying common shares, with each warrant giving the option to acquire 1,6367 common shares at a price of USD 0,2641 per common share, exercisable through May 12, 2026.
IRSA INVESTMENTS & REPRESENTATIONS INC director Nicolas Bendersky has filed an initial ownership report showing his equity interests in the company. He holds restricted share units covering 61,460 common shares, plus 36,080 common shares and 597 global depositary shares, all held directly.
The restricted share units were granted on March 17, 2026 and are scheduled to vest in two equal tranches of 30,730 common shares each, in January 2027 and January 2028. This filing establishes Bendersky’s starting equity position as a director rather than reporting any new market transactions.
IRSA Investments & Representations Inc director Eduardo S. Elsztain filed an initial Form 3 showing his existing ownership in the company’s securities. He reports indirect warrants to purchase 9,710,622 common shares at an exercise price of $0.2641 per share, which are exercisable until May 12, 2026. He also reports direct holdings of 4,487,686 common shares and 518,834 Global Depositary Shares, along with several large indirect stakes in common shares, including one line for 169,470,987 shares. Some indirect positions are held through entities such as IFISA and CRESUD S.A.C.I.F. y A., and he disclaims beneficial ownership of those shares except to the extent of his pecuniary interest.
IRSA Investments & Representations Inc. Chief Investment Officer Jorge Alberto Cruces reported his equity holdings. He holds restricted share units tied to 49,826 common shares, granted on March 17, 2026, which will vest in two equal tranches of 24,913 shares in January 2027 and January 2028. He also directly owns 24,913 common shares as of this amendment.